Argen X SE EV/EBIT
Quel est le EV/EBIT de Argen X SE?
Le EV/EBIT de Argen X SE est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Argen X SE
Que fait Argen X SE?
Argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Entreprises avec ev/ebit similaire à Argen X SE
- Armadale Capital Plc a EV/EBIT de N/A
- Royal Dutch Shell Plc a EV/EBIT de N/A
- Katanga Mining a EV/EBIT de N/A
- Timex India a EV/EBIT de N/A
- Newmark Security plc a EV/EBIT de N/A
- Sypris Solutions a EV/EBIT de N/A
- Argen X SE a EV/EBIT de N/A
- Bedford Metals Corp a EV/EBIT de N/A
- Royal Dutch Shell Plc a EV/EBIT de N/A
- Royal Helium a EV/EBIT de N/A
- Danakali a EV/EBIT de N/A
- Amrit a EV/EBIT de N/A
- AIM5 Ventures a EV/EBIT de N/A